AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 050 GBX
-0.87%
Market Closed
Updated:
May 6, 2024
AstraZeneca PLC
Gross Profit
|
AstraZeneca PLC
Gross Profit Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Gross Profit
$37.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Gross Profit
£22B
|
CAGR 3-Years
9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Gross Profit
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Gross Profit
$916m
|
CAGR 3-Years
18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Gross Profit
$1.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Gross Profit
£429.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
See Also
What is AstraZeneca PLC's Gross Profit?
Gross Profit
37.7B
USD
37.7B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Gross Profit amounts to 37.7B USD.
What is AstraZeneca PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
6%
6%
Over the last year, the Gross Profit growth was 6%. The average annual Gross Profit growth rates for AstraZeneca PLC have been 21% over the past three years , 16% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
